Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine in Mild Alzheimer's Disease
NCT03250741Phase 2Completed
- Sponsor
- Fondazione Santa Lucia IRCCS
- Start
- Jun 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rotigotine in Alzheimer's disease (AD), sponsored by Fondazione Santa Lucia IRCCS. Started Jun 2016; status: completed.
02
Drugs
rotigotine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03250741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03250741.